HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comprehensive molecular and clinical characterization of NUP98 fusions in pediatric acute myeloid leukemia.

Abstract
NUP98 fusions comprise a family of rare recurrent alterations in AML, associated with adverse outcomes. In order to define the underlying biology and clinical implications of this family of fusions, we performed comprehensive transcriptome, epigenome, and immunophenotypic profiling of 2,235 children and young adults with AML and identified 160 NUP98 rearrangements (7.2%), including 108 NUP98-NSD1 (4.8%), 32 NUP98-KDM5A (1.4%) and 20 NUP98-X cases (0.9%) with 13 different fusion partners. Fusion partners defined disease characteristics and biology; patients with NUP98-NSD1 or NUP98-KDM5A had distinct immunophenotypic, transcriptomic, and epigenomic profiles. Unlike the two most prevalent NUP98 fusions, NUP98-X variants are typically not cryptic. Furthermore, NUP98-X cases are associated with WT1 mutations, and have epigenomic profiles that resemble either NUP98-NSD1 or NUP98-KDM5A. Cooperating FLT3-ITD and WT1 mutations define NUP98-NSD1, and chromosome 13 aberrations are highly enriched in NUP98-KDM5A. Importantly, we demonstrate that NUP98 fusions portend dismal overall survival, with the noteworthy exception of patients bearing abnormal chromosome 13 (clinicaltrials gov. Identifiers: NCT00002798, NCT00070174, NCT00372593, NCT01371981).
AuthorsEline J M Bertrums, Jenny L Smith, Lauren Harmon, Rhonda E Ries, Yi-Cheng J Wang, Todd A Alonzo, Andrew J Menssen, Karen M Chisholm, Amanda R Leonti, Katherine Tarlock, Fabiana Ostronoff, Era L Pogosova-Agadjanyan, Gertjan J L Kaspers, Henrik Hasle, Michael Dworzak, Christiane Walter, Nora Muhlegger, Cristina Morerio, Laura Pardo, Betsy Hirsch, Susana Raimondi, Todd M Cooper, Richard Aplenc, Alan S Gamis, Edward A Kolb, Jason E Farrar, Derek Stirewalt, Xiaotu Ma, Tim I Shaw, Scott N Furlan, Lisa Eidenschink Brodersen, Michael R Loken, Marry M Van den Heuvel-Eibrink, C Michel Zwaan, Timothy J Triche, Bianca F Goemans, Soheil Meshinchi
JournalHaematologica (Haematologica) Vol. 108 Issue 8 Pg. 2044-2058 (08 01 2023) ISSN: 1592-8721 [Electronic] Italy
PMID36815378 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • nuclear pore complex protein 98
  • Nuclear Pore Complex Proteins
  • KDM5A protein, human
  • Retinoblastoma-Binding Protein 2
Topics
  • Child
  • Young Adult
  • Humans
  • Leukemia, Myeloid, Acute (genetics)
  • Mutation
  • Nuclear Pore Complex Proteins (genetics)
  • Gene Expression Profiling
  • Retinoblastoma-Binding Protein 2 (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: